Skip to main content
Premium Trial:

Request an Annual Quote

OpGen to Collaborate with UC Davis on 100K Genome Project

NEW YORK (GenomeWeb News) – OpGen today said that it has entered into a scientific and technical partnership with the University of California, Davis under which the firm will participate in the 100K Genome Project.

The project, which was launched earlier this year, aims to sequence the genomes of 100,000 infectious microorganisms and eventually speed up the diagnosis of foodborne illnesses. Partners announced at the launch of the project were UC Davis, Agilent Technologies, and the US Food and Drug Administration, with the US Centers for Disease Control and Prevention and the US Department of Agriculture noted as collaborators.

OpGen said that UC Davis will integrate the firm's Argus Whole Genome Mapping System into its DNA sequencing workflow for sequence assembly and validation of the microorganisms' genomes. The Gaithersburg, Md.-based firm said that the 100K Genome Project will publish the genomes that are completed and validated using the Argus system to a database and provide access to the genomic maps for public health agencies around the world.

"Whole Genome Mapping provides an independent method to detect sequence variations and misassemblies, and aids us in closing the gaps," Bart Weimer, professor in the Department of Population and Reproduction, School of Veterinary Medicine, at UC Davis, and director of the 100K Pathogen Genome Project, said in a statement. "Final Whole Genome Maps will assist health agencies in outbreak management of food borne diseases which cause tremendous risk to public health."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.